06/22/22 9:00 AMOTC : NNMX clinical triallow floatNanomix Initiates New Clinical Study for the eLab S1 Panel Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile,RHEA-AIneutral
06/14/22 9:00 AMOTC : NNMX low floatNanomix Receives IVDR Certification for the eLab AnalyzerNanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile,RHEA-AIneutral
05/26/22 8:30 AMOTC : NNMX low floatNanomix Granted CE Mark for eLab S1 Assay Panel for Whole Blood SamplesNanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics, today announced that it has received European CE mark designation for its eLab S1 assay panel for useRHEA-AIneutral
05/23/22 8:30 AMOTC : NNMX low floatNanomix Announces Upgrade to OTCQB® Venture MarketNanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics, is pleased to announce that it has upgraded to the OTCQB® Venture Market (“OTCQB“), and will continueRHEA-AIneutral
05/20/22 8:30 AMOTC : NNMX covid-19low floatNanomix Receives CE Mark for its eLab COVID-19 Rapid Point-of-Care Antigen PanelNanomix Corporation (OTCBB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics, today announced that it has received the CE mark for its eLab COVID-19 rapid antigen test. The COVID-19RHEA-AIneutral
03/30/22 8:00 AMOTC, Nasdaq : NNMXD, NNMX managementlow floatNanomix Appoints Vidur Sahney as Chief Operating OfficerNanomix Corporation, a leader in the development of mobile, affordable, point-of-care diagnostics, announces the appointment of Vidur Sahney as Chief Operating Officer. Mr. Sahney brings to Nanomix more than 20 years of experience in operations, quality, validation, manufacturing and research. In this newly created executive management position, Mr. Sahney...RHEA-AIneutral
03/25/22 8:00 AMOTC, Nasdaq : NNMXD, NNMX low floatNanomix Corporation Announces Securities Purchase Agreement With GHS Investments for up to $3.0 MillionNanomix Corporation, a leader in the development of mobile, affordable, point-of-care diagnostics, announces it has entered into a $3.0 million securities purchase agreement with GHS Investments, LLC, a leading private investment and management group. GHS has an impressive track record of investing in small-cap companies with a promising outlook, and we...RHEA-AIneutral
03/22/22 8:00 AMOTC, Nasdaq : NNMXD, NNMX conferenceslow floatNanomix to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-VestNanomix Corporation, a leader in the development of mobile, affordable, point-of-care diagnostics, today announced that David Ludvigson, President and Chief Executive Officer, will participate in the 2022 Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-Vest, being held virtually March 28-30, 2022. During this virtual conference,...RHEA-AIneutral
03/02/22 7:00 AMOTC : NNMX low floatNanomix Completes 1-for-173 Reverse Stock SplitNanomix Corporation, a leader in the development of mobile, affordable, point-of-care diagnostics, today announced it has completed the previously announced reverse stock split of its outstanding shares of common stock at a ratio of 1- for-173. The reverse stock split was announced on June 29, 2021 in conjunction with the reverse merger with Boston...RHEA-AIneutral
12/08/21 4:05 PMOTC : NNMX low floatNanomix Announces UK MHRA Registration for New Point of Care SystemNanomix Corporation, a leader in the development of mobile, affordable, point-of-care diagnostics, today announced confirmation of registration from the Medicines& Healthcare products Regulatory Agency of the United Kingdom for the Nanomix eLab system and the S1 Panel Cartridge. The Nanomix eLab analyzer with S1 Panel Cartridge provides multiple...RHEA-AIneutral